Sunshine Biopharma
Price & Volume
Stats
See more52W Range | $1.50-$213.80 |
Market Cap | $5.3M |
Shares Short | 113,084 |
Financials
See moreRevenue (12 Mos) | $32.9M |
Revenue Growth (YoY) | 41.6% |
Gross Profit (12 Mos) | $10.1M |
Diluted EPS | -$127.90 |
News
See moreYahoo Finance • 2 years ago
Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-Market
Yahoo Finance • 2 years ago
Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate Update
Yahoo Finance • 2 years ago
Sunshine Biopharma Announces the Acquisition of Nora Pharma, Adding $10.7 Million in Revenue
About
CEO | Dr. Steve N. Slilaty Ph.D. |
CFO | Mr. Camille Sebaaly |
Address | 333 Las Olas Way, Fort Lauderdale, FL, United States, 33301 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 0 |
